Anna B Gonzalez1, Luciana Young2, Jennifer A Doll3, Gina M Morgan4, Susan E Crawford5, Beth A Plunkett6. 1. Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, IL. Electronic address: Annabee77@hotmail.com. 2. Department of Pediatric Cardiology, Ann and Robert H. Lurie Children's Hospital, Chicago, IL. 3. Department of Biomedical Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI. 4. Department of Internal Medicine, University of Iowa School of Medicine, Iowa City, IA. 5. Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO. 6. Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, IL.
Abstract
OBJECTIVE: We sought to determine if fetal hypertrophic cardiomyopathy (HCM) or cardiac dysfunction is associated with elevated maternal or neonatal insulin-like growth factor (IGF)-I levels in women with diabetes. STUDY DESIGN: In a prospective cohort study, fetal echocardiogram findings at 36 weeks' gestation in women with pregestational diabetes mellitus were compared to those in women without diabetes mellitus. HCM was defined as septal or free wall thickness ≥5 mm and cardiac dysfunction as a modified myocardial performance index ≥0.43. Cord serum IGF-I levels at delivery were measured with enzyme-linked immunosorbent assay. Neonates with abnormal fetal echocardiogram were followed up until resolution or 6 months of life. RESULTS: In all, 75 participants completed fetal echocardiography (55 diabetics and 20 controls). In the diabetic group, 33 of 55 (60%) had abnormal fetal echocardiograms with cardiac dysfunction in 21 of 55 (38.2%) and HCM in 8 of 55 (14.5%) and both in 4 of 55 (7.3%). At 6 months of age, 1 of 12 (8%) had persistent HCM. None in the comparison group had abnormal findings. There were no significant clinical differences in those diabetic women with normal vs abnormal fetal echocardiograms. However, among diabetic women, mean neonatal IGF-I was significantly higher in fetuses with HCM (80 ± 16 ng/mL) as compared to those without HCM (61 ± 18 ng/mL), (P < .001). CONCLUSION: Elevated neonatal IGF-I appears to be associated with fetal HCM in fetuses of diabetic women.
OBJECTIVE: We sought to determine if fetal hypertrophic cardiomyopathy (HCM) or cardiac dysfunction is associated with elevated maternal or neonatal insulin-like growth factor (IGF)-I levels in women with diabetes. STUDY DESIGN: In a prospective cohort study, fetal echocardiogram findings at 36 weeks' gestation in women with pregestational diabetes mellitus were compared to those in women without diabetes mellitus. HCM was defined as septal or free wall thickness ≥5 mm and cardiac dysfunction as a modified myocardial performance index ≥0.43. Cord serum IGF-I levels at delivery were measured with enzyme-linked immunosorbent assay. Neonates with abnormal fetal echocardiogram were followed up until resolution or 6 months of life. RESULTS: In all, 75 participants completed fetal echocardiography (55 diabetics and 20 controls). In the diabetic group, 33 of 55 (60%) had abnormal fetal echocardiograms with cardiac dysfunction in 21 of 55 (38.2%) and HCM in 8 of 55 (14.5%) and both in 4 of 55 (7.3%). At 6 months of age, 1 of 12 (8%) had persistent HCM. None in the comparison group had abnormal findings. There were no significant clinical differences in those diabeticwomen with normal vs abnormal fetal echocardiograms. However, among diabeticwomen, mean neonatal IGF-I was significantly higher in fetuses with HCM (80 ± 16 ng/mL) as compared to those without HCM (61 ± 18 ng/mL), (P < .001). CONCLUSION: Elevated neonatal IGF-I appears to be associated with fetal HCM in fetuses of diabeticwomen.
Authors: Beth A Plunkett; Steven J Weiner; George R Saade; Michael A Belfort; Sean C Blackwell; John M Thorp; Alan T N Tita; Russell S Miller; David S McKenna; Edward K S Chien; Dwight J Rouse; Yasser Y El-Sayed; Yoram Sorokin; Steve N Caritis Journal: Am J Perinatol Date: 2022-04-05 Impact factor: 3.079
Authors: Yanqing Wu; E Albert Reece; Jianxiang Zhong; Daoyin Dong; Wei-Bin Shen; Christopher R Harman; Peixin Yang Journal: Am J Obstet Gynecol Date: 2016-03-31 Impact factor: 8.661
Authors: Nicholas Jex; Amrit Chowdhary; Sharmaine Thirunavukarasu; Henry Procter; Anshuman Sengupta; Pavithra Natarajan; Sindhoora Kotha; Ana-Maria Poenar; Peter Swoboda; Hui Xue; Richard M Cubbon; Peter Kellman; John P Greenwood; Sven Plein; Stephen Page; Eylem Levelt Journal: Diabetes Care Date: 2022-08-01 Impact factor: 17.152
Authors: A L Depla; L De Wit; T J Steenhuis; M G Slieker; D N Voormolen; P G Scheffer; R De Heus; B B Van Rijn; M N Bekker Journal: Ultrasound Obstet Gynecol Date: 2021-04 Impact factor: 7.299